Injectables' key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes.

Injectables' key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes.

<h4>Background</h4>Since a meta-analysis showed little or no effect of second-line injectables on treatment success, and using injectables may induce ototoxicity, injectable-free rifampicin-resistant tuberculosis (RR-TB) treatment regimens are recommended. However, acquired resistance pr...

Full description

Bibliographic Details
Main Authors: Tom Decroo, Aung Kya Jai Maug, Mohamed Anwar Hossain, Cécile Uwizeye, Mourad Gumusboga, Tine Demeulenaere, Nimer Ortuño-Gutiérrez, Bouke C de Jong, Armand Van Deun
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0238016

Internet

https://doi.org/10.1371/journal.pone.0238016

Similar Items